UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2024

 

 

 

Commission File Number: 001-39703

 

 

 

Yatsen Holding Limited

 

Building 35, No. 2519 East Xingang Road

Haizhu District, Guangzhou 510330

People’s Republic of China

 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F Form 40-F

 

 

 


EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press Release – Yatsen Announces Fourth Quarter and Full Year 2023 Financial Results

 

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

YATSEN HOLDING LIMITED

 

 

 

 

 

 

By:

 

/s/ Donghao Yang

Name:

 

Donghao Yang

Title:

 

Chief Financial Officer

 

Date: March 6, 2024


 

Exhibit 99.1

Yatsen Announces Fourth Quarter and Full Year 2023 Financial Results

 

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on March 6, 2024

 

GUANGZHOU, China, March 6, 2024 – Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023.

 

Fourth Quarter and Full Year 2023 Highlights

 

Total net revenues for the fourth quarter of 2023 increased by 6.7% to RMB1.07 billion (US$151.1 million) from RMB1.01 billion for the prior year period. Total net revenues for the full year of 2023 decreased by 7.9% to RMB3.41 billion (US$481.0 million) from RMB3.71 billion for the prior year period.

 

Total net revenues from Skincare Brands1 for the fourth quarter of 2023 increased by 17.6% to RMB554.8 million (US$78.1 million) from RMB471.6 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the fourth quarter of 2023 increased to 51.7% from 46.9% for the prior year period. Total net revenues from Skincare Brands for the full year of 2023 increased by 11.4% to RMB1.38 billion (US$194.9 million) from RMB1.24 billion for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the full year of 2023 increased to 40.5% from 33.5% for the prior year period.

 

Gross margin for the fourth quarter of 2023 was 73.7%, as compared with 71.1% for the prior year period. Gross margin for the full year of 2023 was 73.6%, as compared with 68.0% for the prior year period.
Net loss for the fourth quarter of 2023 was RMB494.5 million (US$69.7 million), as compared with RMB55.0 million for the prior year period. Net loss for the full year of 2023 decreased by 8.7% to RMB750.2 million (US$105.7 million) from RMB821.3 million for the prior year period. Non-GAAP net loss2 for the fourth quarter of 2023 was RMB93.7 million (US$13.2 million), as compared with non-GAAP net income of RMB34.7 million for the prior year period. Non-GAAP net loss for the full year of 2023 decreased by 34.6% to RMB296.1 million (US$41.7 million) from RMB452.9 million for the prior year period.

 

1 Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom, Abby’s Choice and other skincare brands of the Company.

2 Non-GAAP net income (loss) is a non-GAAP financial measure. Effective from the fourth quarter of 2023, non-GAAP net income (loss) is defined as net loss excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill and (v) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) for the prior year period presented in this document is also calculated in the same manner.

 

Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, “We were pleased to return to a growth trajectory in the fourth quarter of 2023 as we made further progress on our strategic transformation plan. Driven by solid performances from Galénic, DR.WU and Eve Lom, revenues from our Skincare Brands increased by 17.6% and 11.4% year over year for the fourth quarter and the full year of 2023, respectively. Perfect Diary’s brand repositioning also

 


 

continued to gain traction. Propelled by the success of the brand’s new hero product, Biolip Essence Lipstick, Perfect Diary rose to second place in the lipstick category in terms of retail sales value on Tmall and Douyin combined for December 2023. Looking ahead, we will remain focused on pursuing sustainable growth with ongoing innovation across our brands.”

 

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, “We recorded a year-over-year increase of 6.7% in total net revenues for the fourth quarter of 2023, returning to growth and beating our previous guidance. Notably, our three major skincare brands recorded a 23.4% year-over-year growth for the fourth quarter and a 22.1% year-over-year growth for the full year of 2023 in combined net revenues. Furthermore, our gross margin improved to 73.7% for the fourth quarter from 71.1% for the prior year period and to 73.6% for the full year from 68.0% a year ago. During the fourth quarter, we recorded a goodwill impairment of RMB354.0 million. Our net loss margin was 22.0% in 2023, as compared with 22.2% in 2022. Our non-GAAP net loss margin narrowed to 8.7% in 2023 from 12.2% a year ago. With cash, restricted cash and short-term investments of RMB2.08 billion, we are confident in our ability to advance our strategic plan going forward.”

 

 

Fourth Quarter 2023 Financial Results

 

Net Revenues

 

Total net revenues for the fourth quarter of 2023 increased by 6.7% to RMB1.07 billion (US$151.1 million) from RMB1.01 billion for the prior year period. The increase was primarily attributable to a 17.6% year-over-year increase in net revenues from Skincare Brands, partially offset by a 1.8% year-over-year decrease in net revenues from Color Cosmetics Brands.3

 

3 Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

 

Gross Profit and Gross Margin

 

Gross profit for the fourth quarter of 2023 increased by 10.6% to RMB790.1 million (US$111.3 million) from RMB714.6 million for the prior year period. Gross margin for the fourth quarter of 2023 increased to 73.7% from 71.1% for the prior year period. The increase was driven by increasing sales of higher-gross margin products and more disciplined pricing and discount policies across all of the Company’s brand portfolio.

 

 

Operating Expenses

 

Total operating expenses for the fourth quarter of 2023 increased by 67.7% to RMB1.33 billion (US$187.3 million) from RMB792.9 million for the prior year period. As a percentage of total net revenues, total operating expenses for the fourth quarter of 2023 were 124.0%, as compared with 78.9% for the prior year period.

 

Fulfillment Expenses. Fulfillment expenses for the fourth quarter of 2023 were RMB62.7 million (US$8.8 million), as compared with RMB62.5 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the fourth quarter of 2023 decreased to 5.8% from 6.2% for the prior year period. The decrease was primarily attributable to further improvements in logistics efficiency.

 

 


 

 

Selling and Marketing Expenses. Selling and marketing expenses for the fourth quarter of 2023 were RMB717.4 million (US$101.0 million), as compared with RMB535.2 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the fourth quarter of 2023 increased to 66.9% from 53.2% for the prior year period. The increase was primarily due to the Perfect Diary brand upgrade as well as the Company’s investments in new product launches across its brands.
General and Administrative Expenses. General and administrative expenses for the fourth quarter of 2023 were RMB158.7 million (US$22.4 million), as compared with RMB169.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the fourth quarter of 2023 decreased to 14.8% from 16.9% for the prior year period. The decrease was primarily attributable to a reduction in share-based compensation.

 

Research and Development Expenses. Research and development expenses for the fourth quarter of 2023 were RMB36.9 million (US$5.2 million), as compared with RMB25.1 million for the prior year period. As a percentage of total net revenues, research and development expenses for the fourth quarter of 2023 increased to 3.4% from 2.5% for the prior year period. The increase was primarily attributable to an increase in personnel costs, reflecting the Company’s commitment to enhancing its research and development capabilities.
Impairment of Goodwill. Impairment of goodwill for the fourth quarter of 2023 was RMB354.0 million (US$49.9 million), as compared with nil in the prior year period. Impairment recorded in this quarter represents the amount by which the carrying value of the Eve Lom reporting unit exceeded its fair value, based on quantitative goodwill impairment test, primarily due to weaker operating results than expected at the time of acquisition.

 

Loss from Operations

 

Loss from operations for the fourth quarter of 2023 was RMB539.6 million (US$76.0 million), as compared with RMB78.2 million for the prior year period. Operating loss margin was 50.3%, as compared with 7.8% for the prior year period.

Non-GAAP loss from operations4 for the fourth quarter of 2023 was RMB125.9 million (US$17.7 million), as compared with non-GAAP income from operations of RMB11.5 million for the prior year period. Non-GAAP operating loss margin was 11.7%, as compared with non-GAAP operating income margin of 1.1% for the prior year period.

Net Loss

Net loss for the fourth quarter of 2023 was RMB494.5 million (US$69.7 million), as compared with RMB55.0 million for the prior year period. Net loss margin was 46.1%, as compared with 5.5% for the prior year period. Net loss attributable to Yatsen’s ordinary shareholders per diluted ADS5 for the fourth quarter of 2023 was RMB0.91 (US$0.13), as compared with RMB0.09 for the prior year period.

 

 


 

Non-GAAP net loss for the fourth quarter of 2023 was RMB93.7 million (US$13.2 million), as compared with non-GAAP net income of RMB34.7 million for the prior year period. Non-GAAP net loss margin was 8.7%, as compared with non-GAAP net income margin of 3.4% for the prior year period. Non-GAAP net loss attributable to Yatsen’s ordinary shareholders per diluted ADS6 for the fourth quarter of 2023 was RMB0.17 (US$0.02), as compared with non-GAAP net income attributable to Yatsen’s ordinary shareholders per diluted ADS of RMB0.06 for the prior year period.

 

 

4 Non-GAAP income (loss) from operations is a non-GAAP financial measure. Effective from the fourth quarter of 2023, non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP income (loss) from operations for the prior year period presented in this document is also calculated in the same manner.

5 ADS refers to American depositary shares, each of which represents four Class A ordinary shares.

6 Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Effective from the fourth quarter of 2023, non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) tax effects on non-GAAP adjustments and (vi) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS for the prior year period presented in this document is also calculated in the same manner.

 

Full Year 2023 Financial Results

 

Total net revenues for the full year of 2023 decreased by 7.9% to RMB3.41 billion (US$481.0 million) from RMB3.71 billion for the prior year period, primarily attributable to the decline in net revenues from Color Cosmetics Brands, partially offset by the increase in net revenues from Skincare Brands.

Gross profit for the full year of 2023 decreased by 0.2% to RMB2.51 billion (US$354.0 million) from RMB2.52 billion for the prior year period. Gross margin for the full year of 2023 was 73.6%, as compared with 68.0% for the prior year period. The increase was primarily attributable to (i) increasing sales of higher-gross margin products from Skincare Brands, (ii) more disciplined pricing and discount policies, and (iii) cost optimization across all of the Company’s brand portfolio.

Loss from operations for the full year of 2023 was RMB913.4 million (US$128.6 million), as compared with RMB928.9 million for the prior year period.

Non-GAAP loss from operations for the full year of 2023 was RMB427.5 million (US$60.2 million), as compared with RMB539.3 million for the prior year period.

Net loss for the full year of 2023 was RMB750.2 million (US$105.7 million), as compared with RMB821.3 million for the prior year period. Net loss attributable to Yatsen’s ordinary shareholders per diluted ADS for the full year of 2023 was RMB1.36 (US$0.19), as compared with RMB1.37 for the prior year period.

 


 

Non-GAAP net loss for the full year of 2023 was RMB296.1 million (US$41.7 million), as compared with RMB452.9 million for the prior year period. Non-GAAP net loss attributable to Yatsen’s ordinary shareholders per diluted ADS for the full year of 2023 was RMB0.53 (US$0.07), as compared with RMB0.76 for the prior year period.

 

Balance Sheet and Cash Flow

 

As of December 31, 2023, the Company had cash, restricted cash and short-term investments of RMB2.08 billion (US$292.5 million), as compared with RMB2.63 billion as of December 31, 2022.

Net cash generated from operating activities for the fourth quarter of 2023 was RMB90.5 million (US$12.8 million), as compared with net cash generated from operating activities of RMB106.6 million for the prior year period. Net cash used in operating activities for the full year of 2023 was RMB107.4 million (US$15.1 million), as compared with net cash generated from operating activities of RMB136.2 million for the prior year period.

 

Business Outlook

 

For the first quarter of 2024, the Company expects its total net revenues to be between RMB765.4 million and RMB803.7 million, representing a year-over-year increase of approximately 0% to 5%. These forecasts reflect the Company’s current and preliminary views on the market and operational conditions, which are subject to change.

 

 

Exchange Rate

 

This announcement contains translations of certain Renminbi (“RMB”) amounts into U.S. dollars (“US$”) at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB7.0999 to US$1.00, the exchange rate in effect as of December 29, 2023, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

 

 


 

Conference Call Information

 

The Company’s management will hold a conference call on Wednesday, March 6, 2024, at 7:30 A.M. U.S. Eastern Time or 8:30 P.M. Beijing Time to discuss its financial results and operating performance for the fourth quarter and full year 2023.

 

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

Conference ID:

8685896

 

 

The replay will be accessible through March 13, 2024, by dialing the following numbers:

 

United States:

+1-877-344-7529

International:

+1-412-317-0088

Replay Access Code:

8685896

 

A live and archived webcast of the conference call will also be available on the Company’s investor relations website at http://ir.yatsenglobal.com/.

 

 

 


 

About Yatsen Holding Limited

 

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly both online and offline, with expansive presence across all major e-commerce, social and content platforms in China.

 

For more information, please visit http://ir.yatsenglobal.com/.

 

Use of Non-GAAP Financial Measures

 

The Company uses non-GAAP income (loss) from operations, non-GAAP net income (loss), non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill and (v) tax effects on non-GAAP adjustments. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) tax effects on non-GAAP adjustments and (vi) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen’s non-GAAP financial measure to the most comparable U.S. GAAP measure are included at the end of this press release.

 

 


 

Safe Harbor Statement

 

This announcement contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (“SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, which include but not limited to the following: the Company’s growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China’s beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

 

For investor and media inquiries, please contact:

 

In China:

 

Yatsen Holding Limited

Investor Relations

E-mail: ir@yatsenglobal.com

 

Piacente Financial Communications

Hui Fan

Tel: +86-10-6508-0677

E-mail: yatsen@thepiacentegroup.com

 

In the United States:

 

Piacente Financial Communications

Brandi Piacente

Tel: +1-212-481-2050

E-mail: yatsen@thepiacentegroup.com

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

 

2022

 

 

2023

 

 

2023

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Assets

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

1,512,945

 

 

 

836,888

 

 

 

117,873

 

Restricted Cash

 

 

-

 

 

 

21,248

 

 

 

2,993

 

Short-term investments

 

 

1,072,867

 

 

 

1,218,481

 

 

 

171,619

 

Accounts receivable, net

 

 

200,843

 

 

 

198,851

 

 

 

28,008

 

Inventories, net

 

 

423,287

 

 

 

352,090

 

 

 

49,591

 

Prepayments and other current assets

 

 

292,825

 

 

 

303,841

 

 

 

42,795

 

Amounts due from related parties

 

 

5,654

 

 

 

20,200

 

 

 

2,845

 

Total current assets

 

 

3,508,421

 

 

 

2,951,599

 

 

 

415,724

 

Non-current assets

 

 

 

 

 

 

 

 

 

Restricted cash

 

 

41,383

 

 

 

-

 

 

 

-

 

Investments

 

 

502,579

 

 

 

618,752

 

 

 

87,149

 

Property and equipment, net

 

 

75,619

 

 

 

64,878

 

 

 

9,138

 

Goodwill, net

 

 

857,145

 

 

 

556,567

 

 

 

78,391

 

Intangible assets, net

 

 

689,669

 

 

 

671,396

 

 

 

94,564

 

Deferred tax assets

 

 

1,951

 

 

 

1,375

 

 

 

194

 

Right-of-use assets, net

 

 

133,004

 

 

 

114,348

 

 

 

16,106

 

Other non-current assets

 

 

52,885

 

 

 

27,100

 

 

 

3,817

 

Total non-current assets

 

 

2,354,235

 

 

 

2,054,416

 

 

 

289,359

 

Total assets

 

 

5,862,656

 

 

 

5,006,015

 

 

 

705,083

 

Liabilities, redeemable non-controlling interests and shareholders' equity

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

119,847

 

 

 

105,691

 

 

 

14,886

 

Advances from customers

 

 

16,652

 

 

 

41,579

 

 

 

5,856

 

Accrued expenses and other liabilities

 

 

323,259

 

 

 

391,217

 

 

 

55,102

 

Amounts due to related parties

 

 

27,242

 

 

 

9,431

 

 

 

1,328

 

Income tax payables

 

 

21,826

 

 

 

17,946

 

 

 

2,528

 

Lease liabilities due within one year

 

 

79,586

 

 

 

45,464

 

 

 

6,403

 

Total current liabilities

 

 

588,412

 

 

 

611,328

 

 

 

86,103

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

113,441

 

 

 

111,591

 

 

 

15,717

 

Deferred income-non current

 

 

45,280

 

 

 

30,556

 

 

 

4,304

 

Lease liabilities

 

 

52,997

 

 

 

67,767

 

 

 

9,545

 

Total non-current liabilities

 

 

211,718

 

 

 

209,914

 

 

 

29,566

 

Total liabilities

 

 

800,130

 

 

 

821,242

 

 

 

115,669

 

Redeemable non-controlling interests

 

 

339,924

 

 

 

51,466

 

 

 

7,249

 

Shareholders’ equity

 

 

 

 

 

 

 

 

 

Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary shares authorized, comprising of 6,000,000,000 Class A ordinary shares, 960,852,606 Class B ordinary shares and 3,039,147,394 shares each of such classes to be designated as of December 31, 2022 and December 31, 2023; 2,030,600,883 Class A shares and 666,572,880 Class B ordinary shares issued as of December 31, 2022 and December 31, 2023; 1,569,677,384 Class A ordinary shares and 666,572,880 Class B ordinary shares outstanding as of December 31, 2022, 1,487,546,132 Class A ordinary shares and 666,572,880 Class B ordinary shares outstanding as of December 31, 2023)

 

 

173

 

 

 

173

 

 

 

24

 

Treasury shares

 

 

(669,150

)

 

 

(864,568

)

 

 

(121,772

)

Additional paid-in capital

 

 

12,038,802

 

 

 

12,260,208

 

 

 

1,726,814

 

Statutory reserve

 

 

24,177

 

 

 

24,177

 

 

 

3,405

 

Accumulated deficit

 

 

(6,600,365

)

 

 

(7,345,153

)

 

 

(1,034,543

)

Accumulated other comprehensive (loss) income

 

 

(74,195

)

 

 

60,200

 

 

 

8,481

 

Total Yatsen Holding Limited shareholders' equity

 

 

4,719,442

 

 

 

4,135,037

 

 

 

582,409

 

Non-controlling interests

 

 

3,160

 

 

 

(1,730

)

 

 

(244

)

Total shareholders' equity

 

 

4,722,602

 

 

 

4,133,307

 

 

 

582,165

 

Total liabilities, redeemable non-controlling interests and shareholders' equity

 

 

5,862,656

 

 

 

5,006,015

 

 

 

705,083

 

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2022

 

 

2023

 

 

2023

 

 

2022

 

 

2023

 

 

2023

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Total net revenues

 

 

1,005,494

 

 

 

1,072,691

 

 

 

151,085

 

 

 

3,706,122

 

 

 

3,414,774

 

 

 

480,961

 

Total cost of revenues

 

 

(290,886

)

 

 

(282,548

)

 

 

(39,796

)

 

 

(1,187,370

)

 

 

(901,455

)

 

 

(126,967

)

Gross profit

 

 

714,608

 

 

 

790,143

 

 

 

111,289

 

 

 

2,518,752

 

 

 

2,513,319

 

 

 

353,994

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fulfilment expenses

 

 

(62,523

)

 

 

(62,741

)

 

 

(8,837

)

 

 

(269,886

)

 

 

(229,021

)

 

 

(32,257

)

Selling and marketing expenses

 

 

(535,244

)

 

 

(717,439

)

 

 

(101,049

)

 

 

(2,330,480

)

 

 

(2,230,974

)

 

 

(314,226

)

General and administrative expenses

 

 

(169,945

)

 

 

(158,716

)

 

 

(22,355

)

 

 

(720,409

)

 

 

(500,942

)

 

 

(70,556

)

Research and development expenses

 

 

(25,139

)

 

 

(36,851

)

 

 

(5,190

)

 

 

(126,875

)

 

 

(111,698

)

 

 

(15,732

)

Impairment of goodwill

 

 

-

 

 

 

(354,039

)

 

 

(49,865

)

 

 

-

 

 

 

(354,039

)

 

 

(49,865

)

Total operating expenses

 

 

(792,851

)

 

 

(1,329,786

)

 

 

(187,296

)

 

 

(3,447,650

)

 

 

(3,426,674

)

 

 

(482,636

)

Loss from operations

 

 

(78,243

)

 

 

(539,643

)

 

 

(76,007

)

 

 

(928,898

)

 

 

(913,355

)

 

 

(128,642

)

Financial income

 

 

7,456

 

 

 

15,763

 

 

 

2,220

 

 

 

34,656

 

 

 

89,020

 

 

 

12,538

 

Foreign currency exchange gain (loss)

 

 

8,380

 

 

 

6,400

 

 

 

901

 

 

 

(35,357

)

 

 

7,218

 

 

 

1,017

 

(Loss) income from equity method investments, net

 

 

(2,086

)

 

 

4,446

 

 

 

626

 

 

 

12,548

 

 

 

10,122

 

 

 

1,426

 

Impairment of investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,078

)

 

 

-

 

 

 

-

 

Other income, net

 

 

7,717

 

 

 

15,612

 

 

 

2,199

 

 

 

103,501

 

 

 

53,558

 

 

 

7,543

 

Loss before income tax expenses

 

 

(56,776

)

 

 

(497,422

)

 

 

(70,061

)

 

 

(818,628

)

 

 

(753,437

)

 

 

(106,118

)

Income tax benefits (expenses)

 

 

1,823

 

 

 

2,896

 

 

 

408

 

 

 

(2,705

)

 

 

3,210

 

 

 

452

 

Net loss

 

 

(54,953

)

 

 

(494,526

)

 

 

(69,653

)

 

 

(821,333

)

 

 

(750,227

)

 

 

(105,666

)

Net loss attributable to non-controlling interests and redeemable non-controlling interests

 

 

2,705

 

 

 

4,011

 

 

 

565

 

 

 

5,962

 

 

 

5,439

 

 

 

766

 

Accretion to redeemable non-controlling interests

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,975

)

 

 

(419

)

Net loss attributable to Yatsen's shareholders

 

 

(52,248

)

 

 

(490,515

)

 

 

(69,088

)

 

 

(815,371

)

 

 

(747,763

)

 

 

(105,319

)

Shares used in calculating loss per share (1):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Class A and Class B ordinary shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

2,236,277,374

 

 

 

2,146,881,745

 

 

 

2,146,881,745

 

 

 

2,372,728,777

 

 

 

2,195,818,231

 

 

 

2,195,818,231

 

    Diluted

 

 

2,236,277,374

 

 

 

2,146,881,745

 

 

 

2,146,881,745

 

 

 

2,372,728,777

 

 

 

2,195,818,231

 

 

 

2,195,818,231

 

Net loss per Class A and Class B ordinary share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

(0.02

)

 

 

(0.23

)

 

 

(0.03

)

 

 

(0.34

)

 

 

(0.34

)

 

 

(0.05

)

    Diluted

 

 

(0.02

)

 

 

(0.23

)

 

 

(0.03

)

 

 

(0.34

)

 

 

(0.34

)

 

 

(0.05

)

Net loss per ADS (4 ordinary shares equal to 1 ADS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

(0.09

)

 

 

(0.91

)

 

 

(0.13

)

 

 

(1.37

)

 

 

(1.36

)

 

 

(0.19

)

    Diluted

 

 

(0.09

)

 

 

(0.91

)

 

 

(0.13

)

 

 

(1.37

)

 

 

(1.36

)

 

 

(0.19

)

 

 

 


 

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2022

 

 

2023

 

 

2023

 

 

2022

 

 

2023

 

 

2023

 

Share-based compensation expenses are included in the operating expenses as follows:

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Fulfilment expenses

 

 

937

 

 

 

256

 

 

 

36

 

 

 

4,267

 

 

 

2,055

 

 

 

289

 

Selling and marketing expenses

 

 

13,712

 

 

 

3,298

 

 

 

465

 

 

 

62,231

 

 

 

23,518

 

 

 

3,312

 

General and administrative expenses

 

 

57,586

 

 

 

39,688

 

 

 

5,590

 

 

 

248,400

 

 

 

46,902

 

 

 

6,606

 

Research and development expenses

 

 

4,490

 

 

 

1,241

 

 

 

175

 

 

 

25,962

 

 

 

5,027

 

 

 

708

 

Total

 

 

76,725

 

 

 

44,483

 

 

 

6,266

 

 

 

340,860

 

 

 

77,502

 

 

 

10,915

 

(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that are subject to shareholder vote.

 

 


 

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)

 

 

 

For the Three Months Ended December 31,

 

 

For the Year Ended December 31,

 

 

 

2022

 

 

2023

 

 

2023

 

 

2022

 

 

2023

 

 

2023

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

Loss from operations

 

 

(78,243

)

 

 

(539,643

)

 

 

(76,007

)

 

 

(928,898

)

 

 

(913,355

)

 

 

(128,642

)

Share-based compensation expenses

 

 

76,725

 

 

 

44,483

 

 

 

6,266

 

 

 

340,860

 

 

 

77,502

 

 

 

10,915

 

Impairment of goodwill

 

 

-

 

 

 

354,039

 

 

 

49,865

 

 

 

-

 

 

 

354,039

 

 

 

49,865

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

13,063

 

 

 

15,231

 

 

 

2,145

 

 

 

48,700

 

 

 

54,297

 

 

 

7,648

 

Non-GAAP income (loss) from operations

 

 

11,545

 

 

 

(125,890

)

 

 

(17,731

)

 

 

(539,338

)

 

 

(427,517

)

 

 

(60,214

)

Net loss

 

 

(54,953

)

 

 

(494,526

)

 

 

(69,653

)

 

 

(821,333

)

 

 

(750,227

)

 

 

(105,666

)

Share-based compensation expenses

 

 

76,725

 

 

 

44,483

 

 

 

6,266

 

 

 

340,860

 

 

 

77,502

 

 

 

10,915

 

Impairment of goodwill

 

 

-

 

 

 

354,039

 

 

 

49,865

 

 

 

-

 

 

 

354,039

 

 

 

49,865

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

13,063

 

 

 

15,231

 

 

 

2,145

 

 

 

48,700

 

 

 

54,297

 

 

 

7,648

 

Revaluation of investments on the share of equity method investments

 

 

2,071

 

 

 

(10,337

)

 

 

(1,456

)

 

 

(12,779

)

 

 

(22,324

)

 

 

(3,144

)

Tax effects on non-GAAP adjustments

 

 

(2,229

)

 

 

(2,635

)

 

 

(371

)

 

 

(8,360

)

 

 

(9,356

)

 

 

(1,318

)

Non-GAAP net income (loss)

 

 

34,677

 

 

 

(93,745

)

 

 

(13,204

)

 

 

(452,912

)

 

 

(296,069

)

 

 

(41,700

)

Net loss attributable to Yatsen's shareholders

 

 

(52,248

)

 

 

(490,515

)

 

 

(69,088

)

 

 

(815,371

)

 

 

(747,763

)

 

 

(105,319

)

Share-based compensation expenses

 

 

76,725

 

 

 

44,483

 

 

 

6,266

 

 

 

340,860

 

 

 

77,502

 

 

 

10,915

 

Impairment of goodwill

 

 

-

 

 

 

354,039

 

 

 

49,865

 

 

 

-

 

 

 

354,039

 

 

 

49,865

 

Amortization of intangible assets resulting from assets and business acquisitions

 

 

12,780

 

 

 

14,945

 

 

 

2,105

 

 

 

47,663

 

 

 

53,214

 

 

 

7,495

 

Revaluation of investments on the share of equity method investments

 

 

2,071

 

 

 

(10,337

)

 

 

(1,456

)

 

 

(12,779

)

 

 

(22,324

)

 

 

(3,144

)

Tax effects on non-GAAP adjustments

 

 

(2,229

)

 

 

(2,635

)

 

 

(371

)

 

 

(8,360

)

 

 

(9,356

)

 

 

(1,318

)

Accretion to redeemable non-controlling interests

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,975

 

 

 

419

 

Non-GAAP net income (loss) attributable to Yatsen's shareholders

 

 

37,099

 

 

 

(90,020

)

 

 

(12,679

)

 

 

(447,987

)

 

 

(291,713

)

 

 

(41,087

)

Shares used in calculating loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of Class A and Class B ordinary shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

2,236,277,374

 

 

 

2,146,881,745

 

 

 

2,146,881,745

 

 

 

2,372,728,777

 

 

 

2,195,818,231

 

 

 

2,195,818,231

 

    Diluted

 

 

2,343,024,839

 

 

 

2,146,881,745

 

 

 

2,146,881,745

 

 

 

2,372,728,777

 

 

 

2,195,818,231

 

 

 

2,195,818,231

 

Non-GAAP net income (loss) attributable to ordinary shareholders per Class A and Class B ordinary share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

0.02

 

 

 

(0.04

)

 

 

(0.01

)

 

 

(0.19

)

 

 

(0.13

)

 

 

(0.02

)

    Diluted

 

 

0.02

 

 

 

(0.04

)

 

 

(0.01

)

 

 

(0.19

)

 

 

(0.13

)

 

 

(0.02

)

Non-GAAP net income (loss) attributable to ordinary shareholders per ADS (4 ordinary shares equal to 1 ADS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic

 

 

0.07

 

 

 

(0.17

)

 

 

(0.02

)

 

 

(0.76

)

 

 

(0.53

)

 

 

(0.07

)

    Diluted

 

 

0.06

 

 

 

(0.17

)

 

 

(0.02

)

 

 

(0.76

)

 

 

(0.53

)

 

 

(0.07

)

 

 



Yatsen (NYSE:YSG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Yatsen Charts.
Yatsen (NYSE:YSG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Yatsen Charts.